Navigation Links
GeoVax's DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
Date:10/20/2008

ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based biotechnology company, developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today it has shipped both DNA and MVA components of its AIDS vaccine to the HIV Vaccine Trials Network (HVTN) pharmacy, for use in the upcoming Phase 2a human clinical trial. This Phase 2a study will involve 150 vaccinees and 75 placebo (control) participants. These trials serve as a major milestone, as Phase 2a trials are the most advanced trials to-date for GeoVax.

Dr. Robert McNally, President and CEO of GeoVax Labs Inc., commented, "The shipment of the vaccine to the HIV Vaccine Trials Network is a significant step in preparation for the largest clinical trial yet to be undertaken by GeoVax. Multiple completed Phase 1 safety trials refined the dose and vaccine delivery intervals to optimize the immune responses considered desirable to achieve protection against the HIV-1 virus causing AIDS."

Further, a Biological Master File has been submitted to the Food and Drug Administration (FDA) for review of the manufacturing data for the product shipped to HVTN for use in the Phase 2a trial. The FDA completes its review within four weeks. Upon FDA clearance, HVTN's pharmacy will release GeoVax's DNA and MVA vaccines for its planned Phase 2a trial commencement.

GeoVax AIDS vaccines are designed to prevent development of Acquired Immunodeficiency Disease (AIDS) caused by the virus known as HIV-1 by vaccinating individuals prior to virus infection. The vaccine regimen employs a two component "prime-boost strategy." Trial participants are first administered GeoVax HIV-1 DNA vaccine which "primes" the immune system followed by the second vaccine, GeoVax's HIV-1 MVA (Modified Vaccinia Virus) boost. Both vaccines express the 3 major proteins of the AIDS virus. These proteins mimic more than 50% of the
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
2. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
3. Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today
4. Nanoemulsion vaccines show increasing promise
5. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
6. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
7. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
8. Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016
9. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
10. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
11. GeoVax Presents Data at AIDS Vaccine 2008 Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...
(Date:11/30/2009)..., a leader in providing smart and efficient softwa...Pathology®, evolutionizing work-from-home hist...ard’ software used by 8 of the Top 10 Pharma...ost per slide’ basis. , ... -- PDS has announced another evolution in the his...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNewswire-Fir... of scientific, medical and technical products and...base, its comprehensive biomedical,database which ...an 7,000,active, peer reviewed journals. , ...ment of new biomedical,and pharmaceutical insights...
(Date:11/27/2009)...echanised blue dye test alternative is helping b...rance one step closer for pharma-companies. It is ...ine developed by Sepha for use with blister pack...al and global pharma-companies such as Sanofi-Aven...and productivity improvements on the packaging lin...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3
...- Tiens Biotech Group (USA),Inc. ("the Company" or...m ,announced financial results for the fourth qua...Revenue for the fourth quarter of 2007 was $13.3 m...arter of 2006., Net income for the fourth quarter...pared to net income of $5.9 million, or $0.08 per ...
...-. Actavis Group, the,international generic pharma...eived two separate approvals from the U.S. Food & ...ide extended-release tablets (SR). Distribution,of...on Hydrochloride extended-release tablets (SR), av...ent of Wellbutrin SR(R) and are,indicated for the ...
...rch 28 /PRNewswire-FirstCall/,-- Evotec AG (Frankf...results according to IFRS for the year ended Decem...e driven by strong progress in the,Company,s clini..., the,acquisition of Neuro3d, the sale of Evotec T...ment Business (CPD) and the proposed acquisition o...
Other Biology Technology:Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 2Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 3Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 4Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 5Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 6Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 7Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 8Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 9Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 10Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S. 2Evotec Announces Financial Results for 2007 2Evotec Announces Financial Results for 2007 3Evotec Announces Financial Results for 2007 4Evotec Announces Financial Results for 2007 5Evotec Announces Financial Results for 2007 6Evotec Announces Financial Results for 2007 7Evotec Announces Financial Results for 2007 8
(Date:11/25/2009)...sistant professors recently received funding from ...research beneficial to understanding the environme...er Blackwood, assistant professor in the Departmen...pport two separate research projects. , His firs...mmunities and Functions from the Leaf to the Lands...
(Date:11/24/2009)... a protein that may help gut bacteria bind to the ...by probiotic producers to identify strains that ar...iotics need to interact with cells lining the gut ... surfaces in the gut they are more likely to stick... Dr Nathalie Juge from the Institute of Food Resea...
(Date:11/24/2009)...s long held secrets of the earth,s history locked ...een very little information on the environments th...ons of years. Now, a team of researchers from nine...the tune of $10 million dollars by the National Sc...things literally. These scientists will drill thr...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2RES Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 56542 1RES Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 56542 2Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 1Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 2Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 3Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 4WomenHeart and P A D Coalition Join Forces to Educate Women about Peripheral Arterial Disease 56532 1WomenHeart and P A D Coalition Join Forces to Educate Women about Peripheral Arterial Disease 56532 2WomenHeart and P A D Coalition Join Forces to Educate Women about Peripheral Arterial Disease 56532 3
...z. When the larvae of the primitive social insect...uiet pupal stage, she doesnt know if shell arise a...s with Arizona State Universitys social insect res...w light on the development of colonial insects fro...social order of wasps. In a paper highlighted on t...
...itute of Molecular Virology of the GSF National R...rberg/Munich (Helmholtz Association of German Rese...r cellular components whose make-up is changed as ...th colleagues from the Technical University of Mun...sed micro-array technologies micro-arrays are chi...
... how much information we put in our heads" The ans...50,000-250,000 words. And then there are all the l... we grew up in, the time we spilled orange juice o...quadratic equation (for some of us). , So where d...s, the answer would be easy: we would store memori...
Other Biology News:Old developmental pathways spawn revolutionary evolutionary changes 2Old developmental pathways spawn revolutionary evolutionary changes 3Prions and retroviruses -- an unholy alliance? 2A balanced memory network 2
Nunc OmniTray from Sigma-Aldrich
...of systems provide fast and reliable scalable auto...eomics and drug development laboratories. Staccato...s; Mini Workstation Series, Application Series and... Staccato Application Series systems use a revolut...
...es Systems provide fast and reliable automation fo... drug development laboratories. Staccato Custom Se...ions, providing solutions that are tailored to the...controlled with either Caliper's time proven CLARA...
Corning Spin-X Centrifuge Tube Filters from Sigma-Aldrich
Biology Products: